BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chapelle N, Ben Ghezala I, Barkun A, Bardou M. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD). Expert Opin Pharmacother 2021;22:219-27. [PMID: 32893683 DOI: 10.1080/14656566.2020.1817385] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cho YK, Kim JH, Kim HS, Kim TO, Oh JH, Choi SC, Moon JS, Lee SK, Jung SW, Kim SS, Jung HK, Lee SP, Cheon GJ, Park MI, Jung HY, Ko KH, Sung IK, Lee SH, Lee JY, Lee ST, Rhee PL, Kim N, Hong SJ, Kim HJ, Kim GH, Lee KJ, Kim SK, Shin WG, Lee OY. Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis. Aliment Pharmacol Ther 2023;57:72-80. [PMID: 36314172 DOI: 10.1111/apt.17255] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kucheryavy YA, Andreyev DN, Eryomina EY, Gilmanov AA, Nazarova OV, Sidneva YA, Topalova YG. Efficacy of Esophageal Protector in Treating Gastroesophageal Reflux Disease with Extraesophageal Symptoms: a Multicenter, Open-Label, Observational Study. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;32:38-49. [DOI: 10.22416/1382-4376-2022-32-4-38-49] [Reference Citation Analysis]
3 Li F, Yuan Y, Wu D, Li J, Han H, Li X, Hu L, Chen R, Yao Y, Jiao Y, Chen H, Mao T, Xie C. Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-12. [DOI: 10.1155/2022/9647003] [Reference Citation Analysis]
4 Chhabra P, Ingole N. Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes. Cureus 2022. [DOI: 10.7759/cureus.28563] [Reference Citation Analysis]
5 Huang Q, Zheng S, Cai T, Zhang S, Su Q, Wang F. Factors associated with mood disorders and the efficacy of the targeted treatment of functional dyspepsia: A randomized clinical trial. Front Med 2022;9. [DOI: 10.3389/fmed.2022.859661] [Reference Citation Analysis]
6 Yanushevich OO, Maev IV, Krikheli NI, Andreev DN, Lyamina SV, Sokolov FS, Bychkova MN, Beliy PA, Zaslavskaya KY. Prevalence and Risk of Dental Erosion in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis. Dentistry Journal 2022;10:126. [DOI: 10.3390/dj10070126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Mahajan R, Kulkarni R, Stoopler ET. Gastroesophageal reflux disease and oral health: A narrative review. Spec Care Dentist 2022. [PMID: 35605234 DOI: 10.1111/scd.12726] [Reference Citation Analysis]
8 Hosseini A, Shorofi SA, Jackson AC, Dehghan MF, Salmanpour A, sadeghi Z, Haghani S, Bahramnezhad F. The effects of diaphragmatic breathing training on the quality of life and clinical symptoms of patients with gastroesophageal reflux disease: A randomized controlled trial. Advances in Integrative Medicine 2022. [DOI: 10.1016/j.aimed.2022.03.002] [Reference Citation Analysis]
9 Lu B, Yue P, Shao Q, Mao L, Qiao H. Fertility and early embryonic development toxicity and toxicokinetic study of KFP‐H008 in Sprague–Dawley rats. Birth Defects Research. [DOI: 10.1002/bdr2.2002] [Reference Citation Analysis]
10 Liu TW, Wang CM, Ci YH, Liu J, Qi XS. Effect of psychological problems and interventions on gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1043-1048 [DOI: 10.11569/wcjd.v29.i18.1043] [Reference Citation Analysis]
11 Andreev DN, Zaborovsky AV, Lobanova EG. Gastroesophageal reflux disease: new approaches to optimizing pharmacotherapy. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-5-30-37] [Reference Citation Analysis]